Approval · Notice of Compliance 19436 · 2017
ZEVALIN: Notice of Compliance 19436
Issued June 21, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19436
- Date
- June 21, 2017
- Company
- Servier Canada Inc.Laval, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to the manufacturing sites
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEVALIN | Not yet assigned | — |
Medicinal ingredients
- IBRITUMOMAB TIUXETAN 1.6 MG per ML